The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
The drug will be marketed under the brand name Molnaflu
The company has developed the API in house at its R&D center in Hyderabad
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
The primary objective of the ongoing trial is to determine whether ambrisentan can prevent the progression to respiratory failure and reduce the need for mechanical ventilation, among others
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
Up to 100 million mRNA vaccine doses could be produced in Australia each year
Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities
The total cost of the project is estimated at Rs 30 crore
The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.
Subscribe To Our Newsletter & Stay Updated
